These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1231881

  • 1. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F, Melluso K, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of heparin on HGH secretion after intravenous administration of tolbutamide in normal subjects].
    Ragonese F, Melluso R, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1975-9. PubMed ID: 1231882
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E, Souvatzoglou A, von Werder K.
    Verh Dtsch Ges Inn Med; 1974 Dec 30; 80():1325-8. PubMed ID: 4454412
    [No Abstract] [Full Text] [Related]

  • 4. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A, Ragonese F, Albanese MC, Alibrando S, Allegra V.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):946-52. PubMed ID: 4463984
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA].
    Carducci Artenisio A, Ragonese F, Alibrando A, Forte F, Mancuso T, Consolo F.
    Minerva Med; 1979 May 12; 70(23):1681-6. PubMed ID: 109792
    [No Abstract] [Full Text] [Related]

  • 6. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
    Fossati P, Asfour M, Fourlinnie JC, Cappoen JP, Dalle-Furnari MA, Brion-Brevan B.
    Lille Med; 1976 Nov 12; 19(9):757-65. PubMed ID: 1004102
    [No Abstract] [Full Text] [Related]

  • 7. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M.
    J Clin Invest; 1971 May 12; 50(5):1069-79. PubMed ID: 4928263
    [Abstract] [Full Text] [Related]

  • 8. [Effects of nicotinic acid on the secretion of HGH in normal and obese subjects].
    Carducci Artenisio A, Albanese MC, Ragonese F, Allegra V, Alibrando S.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):953-9. PubMed ID: 4463985
    [No Abstract] [Full Text] [Related]

  • 9. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C, Höffken B, Morgner KD.
    Verh Dtsch Ges Inn Med; 1974 Aug 30; 80():1328-30. PubMed ID: 4454413
    [No Abstract] [Full Text] [Related]

  • 10. Effect of adrenergic blocking agents on growth hormone responses to physical exercise.
    Sutton J, Lazarus L.
    Horm Metab Res; 1974 Sep 30; 6(5):428-9. PubMed ID: 4418466
    [No Abstract] [Full Text] [Related]

  • 11. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D, Zonew I, Milanow S.
    Ther Hung; 1977 Sep 30; 25(4):145-9. PubMed ID: 605413
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone and diabetic angiopathy.
    Lundbaek K.
    Acta Diabetol Lat; 1971 Sep 30; 8 Suppl 1():344-72. PubMed ID: 5146909
    [No Abstract] [Full Text] [Related]

  • 13. [Nervous regulation of pituitary somatotropin secretion].
    Schaub C.
    Neurochirurgie; 1977 Jul 30; 23(2):111-22. PubMed ID: 917181
    [No Abstract] [Full Text] [Related]

  • 14. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F, Villanueva L, Peñalva A, Rodríguez R, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):217-20. PubMed ID: 482694
    [No Abstract] [Full Text] [Related]

  • 15. [GH secretion after L-dopa administration in hepatic cirrhosis].
    Greco AV, Ghirlanda G, Fedeli G, Rebuzzi A, Altomonte L, Manna R.
    Minerva Med; 1976 Oct 06; 67(47):3027-32. PubMed ID: 967366
    [Abstract] [Full Text] [Related]

  • 16. Adrenergic receptor control mechanism for growth hormone secretion.
    Blackard WG, Heidingsfelder SA.
    J Clin Invest; 1968 Jun 06; 47(6):1407-14. PubMed ID: 5653218
    [Abstract] [Full Text] [Related]

  • 17. [Secretion of human growth hormone (HGH). 2. Effects of adrenergic stimulating or blocking drugs on serum HGH].
    Kato Y.
    Nihon Naibunpi Gakkai Zasshi; 1972 Aug 20; 48(5):352-63. PubMed ID: 4404067
    [No Abstract] [Full Text] [Related]

  • 18. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
    Rolandi E, Barreca T, Masturzo P, Polleri A.
    Boll Soc Ital Biol Sper; 1975 Jun 30; 51(12):751-4. PubMed ID: 1222097
    [No Abstract] [Full Text] [Related]

  • 19. [Autonomic nervous system and HCG secretion. II. Effect of adrenergic blockaders on the excretion of HCG following intravenous loading of tolbutamide].
    Carducci Artenisio A, Sprovieri M, Alibrando S, Albanese MC, Allegra V, Ragonese F, Corsi V.
    Folia Endocrinol; 1973 Jun 30; 26(3):206-16. PubMed ID: 4740901
    [No Abstract] [Full Text] [Related]

  • 20. Effect of lipids on growth hormone secretion in humans.
    Blackard WG, Hull EW, Lopez A.
    J Clin Invest; 1971 Jul 30; 50(7):1439-43. PubMed ID: 5090059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.